NASDAQ: LQDA - Liquidia Corporation

Yield per half year: +20.37%
Sector: Healthcare

Share chart Liquidia Corporation

Extended chart Simple chart
Financial Markets by TradingView

About

Liquidia Corporation, биофармацевтическая компания, разрабатывает, производит и продает различные продукты для неудовлетворенных потребностей пациентов в Соединенных Штатах. Его потенциальные продукты включают YUTREPIA, вдыхаемый сухой порошкообразный состав трепростинила для лечения легочной артериальной гипертензии. Компания распространяет общий инъекционный трепростинил в Соединенных Штатах. Liquidia Corporation была основана в 2004 году и имеет штаб-квартиру в Моррисвилле, Северная Каролина.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2018-07-26
ISIN US53635D2027
Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.liquidia.com
Цена ао 11.76
Change price per day: 0% (14.36)
Change price per week: +11.4% (12.89)
Change price per month: +21.69% (11.8)
Change price per 3 month: +30.19% (11.03)
Change price per half year: +20.37% (11.93)
Change price per year: +14.79% (12.51)
Change price per 3 year: +161.09% (5.5)
Change price per 5 year: +190.69% (4.94)
Change price per 10 year: 0% (14.36)
Change price per year to date: +22.11% (11.76)
All parameters

Underestimation

Title Value Grade
P/S 43.19 1
P/BV 15.97 1
P/E 0 0
EV/EBITDA -9.48 0
Total: 2.63

Efficiency

Title Value Grade
ROA, % -65.18 0
ROE, % -165.99 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.0492 10
Total: 9.6

Growth impulse

Title Value Grade
Yield Revenue, % 116.65 10
Yield Ebitda, % 51.59 7
Yield EPS, % -50.41 0
Total: 5
More

Institutions Volume Share, %
Caligan Partners, LP 9243627 14.28
Blackrock Inc. 3238707 5
State Street Corporation 2656906 4.11
Vanguard Group Inc 2576938 3.98
Kynam Capital Management, LP 1642244 2.54
Geode Capital Management, LLC 930875 1.44
Eversept Partners, LP 724406 1.12
Adage Capital Partners GP L.L.C. 707773 1.09
Opaleye Management Inc. 575200 0.89
Two Sigma Advisers, LP 573500 0.89

ETF Share, % Profitability for 1 year, % Dividends, %
SPDR S&P Pharmaceuticals ETF 0.93868 29.8 1.29889
Direxion Daily Pharmaceutical & Medical Bull 3X Shares 0.74922 86.72 1.2989
Virtus LifeSci Biotech Clinical Trials ETF 0.58651 63.04 0.33
SPDR S&P Kensho New Economies Composite ETF 0.38247 21.57 0.88486
iShares Micro-Cap ETF 0.14547 17.09 1.54048
Vanguard U.S. Momentum Factor ETF 0.12 30.05 1.05834
iShares MSCI USA Small-Cap Min Vol Factor ETF 0.07301 18.2 1.66828
iShares Russell 2000 Growth ETF 0.04256 38.04 0.6026
Vanguard Russell 2000 Growth ETF 0.04 23.05 0.60264
Vanguard Russell 2000 ETF 0.02 17.16 1.48801
iShares Morningstar Small-Cap Growth ETF 0.01943 33.63 0.72598
iShares Morningstar Small-Cap Growth ETF 0.01943 587.89 0.72598
ProShares UltraPro Russell2000 0.01239 89.82 1.47873
iShares Morningstar Small-Cap ETF 0.01001 391.25 1.60498
iShares Morningstar Small-Cap ETF 0.01001 30.1 1.60498
Fidelity MSCI Health Care Index ETF 0.00758 3 1.46057
ProShares Hedge Replication ETF 0.0035 5.92 1.47892
Humankind US Stock ETF 0.00307 18.81 1.99919
iShares Russell 3000 ETF 0.00141 24.83 1.43482
Vanguard Russell 3000 ETF 0 31.87 1.43817



Head Job title Payment Year of birth
Dr. Roger A. Jeffs Ph.D. CEO & Director 532.23k 1962 (63 years)
Mr. Michael Kaseta COO & CFO 627.85k 1976 (49 years)
Mr. Russell Schundler General Counsel & Corporate Secretary 541.92k 1975 (50 years)
Mr. William R. Kenan Jr. Co-Founder N/A
Dr. Ginger Denison Co-Founder N/A
Mr. Jason Adair Chief Business Officer N/A 1972 (53 years)
Ms. Sarah Krepp SPHR Vice President of People & Culture N/A
Mr. Scott Moomaw Chief Commercial Officer N/A 1971 (54 years)
Dr. Rajeev Saggar M.D. Chief Medical Officer 1974 (51 year)
Mr. Michael Hunter Senior Vice President of Manufacturing Operations

Address: United States, Morrisville. NC, 419 Davis Drive - open in Google maps, open in Yandex maps
Website: https://www.liquidia.com